Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

Volume:11   Issue:8
Pp: 944-953
H. Huynh, S. P. Choo, H. C. Toh, W. M. Tai, A. Y.F. Chung, P. K.H. Chow, R. Ong and K. C. Soo
DOI: 10.2174/156800911797264716

Order Reprints Order Eprints

Active-Targeted Nanotherapy Strategies for Prostate Cancer

Volume:11   Issue:8
Pp: 954-965
M. Katsogiannou, L. Peng, C. V. Catapano and P. Rocchi
DOI: 10.2174/156800911797264770

Order Reprints Order Eprints

H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma

Volume:11   Issue:8
Pp: 966-975
D. G. Lee, J.-H. Lee, B. K. Choi, M.-J. Kim, S.-M. Kim, K. S. Kim, K. Chang, S. H. Park, Y.-S. Bae and B. S. Kwon
DOI: 10.2174/156800911797264752

Order Reprints Order Eprints

RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors

Volume:11   Issue:8
Pp: 976-986
S. E. Martin, Z.-H. Wu, K. Gehlhaus, T. L. Jones, Y.-W. Zhang, R. Guha, S. Miyamoto, Y. Pommier and N. J. Caplen
DOI: 10.2174/156800911797264734

Order Reprints Order Eprints